Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

LMAT Lemaitre Vascular PE ratio, current and historical analysis

As of May 8, 2025, the Lemaitre Vascular stock's price-to-earnings ratio is 41.58. This results from the current EPS of $1.96 and stock price of $81.5. The PE ratio has decreased by 12% from the past four quarters average of 47.2.

LMAT PE ratio history

How has LMAT's PE ratio performed in the past

The PE ratio of Lemaitre Vascular has averaged 39.21 over the last ten years. The current price-to-earnings ratio of 41.58 is 6% more than the historical average. In the past ten years, LMAT's PE ratio reached its highest point in the Jun 2023 quarter at 59.02, when the stock price was $67.28 and the EPS was $1.14. The lowest point was recorded in the Dec 2018 quarter, when it reached 20.03 with a price of $23.64 and an EPS of $1.18.

Today
41.44
Average
39.21
Median
39.51
Minimum
20.03
Maximum
59.02

Lemaitre Vascular PE ratio by year

Maximum annual increase: 137.32% in 2011

Maximum annual decrease: -64.36% in 2010

Year PE ratio PE change Price EPS
2024 47.01 12.63% $92.14 $1.96
2023 41.74 -14.75% $56.76 $1.36
2022 48.96 23.79% $46.02 $0.94
2021 39.55 2.54% $50.23 $1.27
2020 38.57 -2.38% $40.5 $1.05
2019 39.51 97.25% $35.95 $0.91
2018 20.03 -42.76% $23.64 $1.18
2017 34.99 -21.3% $31.84 $0.91
2016 44.46 13.42% $25.34 $0.57
2015 39.2 22.96% $17.25 $0.44
2014 31.88 -16.41% $7.65 $0.24
2013 38.14 12.97% $8.01 $0.21
2012 33.76 -20.17% $5.74 $0.17
2011 42.29 137.32% $5.92 $0.14
2010 17.82 -64.36% $6.77 $0.38

Lemaitre Vascular PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 47.01 -5.87% $92.14 $1.96
Sep 2024 49.94 3.18% $92.89 $1.86
Jun 2024 48.4 11.6% $82.28 $1.7
Mar 2024 43.37 3.91% $66.36 $1.53
Dec 2023 41.74 -5.76% $56.76 $1.36
Sep 2023 44.29 -24.96% $54.48 $1.23
Jun 2023 59.02 7.78% $67.28 $1.14
Mar 2023 54.76 11.85% $51.47 $0.94
Dec 2022 48.96 -6.3% $46.02 $0.94
Sep 2022 52.25 17% $50.68 $0.97
Jun 2022 44.66 21.1% $45.55 $1.02
Mar 2022 36.88 -6.75% $46.47 $1.26
Dec 2021 39.55 -0.18% $50.23 $1.27
Sep 2021 39.62 -8.46% $53.09 $1.34
Jun 2021 43.28 4.69% $61.02 $1.41

LMAT average PE ratio chart

What is the average PE ratio of LMAT for the past years

Currently, LMAT's PE ratio is above its 10-year historical average, but it is lower than the 3 and 5-year averages.

3-year avg
48.58
5-year avg
44.25
10-year avg
39.21
15-year avg
37.01

LMAT PE vs peers

What is LMAT's PE ratio compared to its peers

LMAT's PE ratio is less than its peer stock BSX, but it is above EW's and TFX's.

Stock name PE ratio Market cap
EW Edwards Lifesciences Corp 10.58 $43.64B
TFX Teleflex Inc 38.42 $5.53B
LMAT Lemaitre Vascular Inc 41.44 $1.83B
BSX Boston Scientific Corp 74.84 $152.8B
ANGO Angiodynamics Inc N/A $370.13M
BAX Baxter International Inc N/A $16.09B

Frequently asked questions

What is Lemaitre Vascular's PE ratio?

LMAT stock has a price to earnings ratio of 41.58 as of May 8, 2025.

What is the 3-year average PE ratio for Lemaitre Vascular (LMAT)?

The average PE ratio for LMAT stock over the past 3 years is 48.58.

What is the 5-year average PE ratio for Lemaitre Vascular (LMAT)?

The average PE ratio for LMAT stock over the past 5 years is 44.25.

What is the highest PE ratio for LMAT?

Over the last ten years, the quarterly PE ratio reached a historic high of 59.02 in the Jun 2023 quarter.

How does the current PE ratio for LMAT compare to its historical average?

LMAT's price to earnings ratio is currently 6% above its 10-year historical average.

How is LMAT's PE ratio calculated (Lemaitre Vascular PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 8, 2025), Lemaitre Vascular's stock price is $81.5. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.96. Therefore, Lemaitre Vascular's price to earnings ratio for today is 41.58. PE RATIO(41.58) = STOCK PRICE($81.5) / TTM EPS($1.96)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.